← Insider buys
SRPT

Sarepta Therapeutics, Inc. · Healthcare

EVP and General Counsel David T Howton sold $9.8M of Sarepta Therapeutics, Inc.

Sold$9,789,000
$125.50Price
78,000Shares
−76%Stake

What SRPT did after the filing

Prices for SRPT after this filing aren't in yet.

Traded Fri, Dec 13. Filed Tue, Dec 17, 8:01 PM ET, after the close. Not investment advice.